Corporate News
Filana Therapeutics (ticker: FLNA) closed the market down 1.52 % on Friday, 23 October 2026, at 06:15 AM Central Europe. At the close, one share of Filana Therapeutics was priced at approximately USD 0.65 on major exchanges.
The company’s current share supply is 48.3 million. Its market capitalization is USD 31.9 million. In the last 24 hours, about USD 162.6 thousand of Filana Therapeutics shares were traded.
From the close of the previous month, Filana Therapeutics has declined 25.29 %. The simple moving average over the last 200 trading days is USD 1.40. The all‑time high over the past 52 weeks was USD 3.94, recorded on 27 October 2025. The 52‑week low was USD 0.64, recorded on 22 October 2026.
Performance of Related Stocks in the Past 24 Hours
| Ticker | Change | Current Price | Market Capitalization |
|---|---|---|---|
| LITS (Lite Strategy) | -4.03 % | USD 1.19 | USD 37.7 million |
| CCEL (Cryo‑cell) | -4.06 % | USD 4.49 | USD 37.7 million |
| PRPO (Precipio) | -3.01 % | USD 20.61 | USD 38 million |
| CIRC (Circle) | -17.04 % | USD 0.29 | USD 37.8 million |
| SCYX (Scynexis) | +0.66 % | USD 3.81 | USD 37.9 million |
About Filana Therapeutics
Cassava Sciences, Inc. is a clinical‑stage biotechnology company headquartered in Austin, Texas, United States. The company focuses on the detection and treatment of neurodegenerative diseases, including Alzheimer’s disease. Cassava Sciences operates within the United States and provides access to its services through the website www.cassavasciences.com . The company entered the public market on the Nasdaq stock exchange on 14 July 2000.
